华富健康文娱灵活配置混合 A

Search documents
基金市场周报:钢铁板块表现较优,主动投资股票基金平均收益相对领先-20250707
Shanghai Securities· 2025-07-07 09:58
证券投资基金研究报告/基金周报 报告日期:2025年07月07日 本期(2025.6.30-2025.7.4)上证指数上涨 1.40%,深证成指上涨 1.25%。申万一级行业涨多跌少,其中钢铁和建筑材料行业表现较好。 海外权益市场重要指数涨多跌少,国际黄金价格上涨。本期各类型基金 均上涨。主动投资股票基金较上期上涨 1.82%,主动投资混合基金上涨 1.25%,主动投资债券基金上涨 0.17%;QDII 基金较上期上涨 0.63%。 图 1、基金指数近一年收益率走势 数据来源:wind,上海证券基金评价研究中心; 起止时间:2024 年 7 月 5 日——2025 年 7 月 4 日 图 2、各类型基金本期收益率(%) 数据来源:wind,上海证券基金评价研究中心;数据截至 2025 年 7 月 4 日 注:主动投资股票基金、混合基金及债券基金平均收益率采用中国开放式主动管理基 金系列指数收益率;其他类型基金平均收益率采用样本基金收益率算术平均值 分析师:池云飞 执业证书编号:S0870521090001 电话:021-53686397 E-mail: chiyunfei@shzq.com 研究助理:汪雪凝 ...
基金市场周报:环保板块表现较优QDII基金平均收益相对领先-20250603
Shanghai Securities· 2025-06-03 09:24
Core Insights - The report indicates that the environmental protection sector performed well during the period, with QDII funds showing an average return that outperformed other fund types [1][7][17] - The Shanghai Composite Index experienced a slight decline of 0.03%, while the Shenzhen Component Index fell by 0.91% during the same period [1] - Among various fund types, QDII funds increased by 1.04%, contrasting with declines in actively managed stock funds, mixed funds, and bond funds [1] Fund Performance Summary - The environmental and pharmaceutical sectors were highlighted as strong performers in the recent 12 periods, with banks and beauty care also showing good performance [7] - Active stock funds focusing on the pharmaceutical sector yielded higher returns, with notable funds such as Hongtu Innovation Healthcare Stock Fund achieving a return of 9.67% [12][13] - In the bond market, convertible bond funds led with an average return of 3.90% year-to-date, while traditional bond funds showed mixed results [15][16] QDII Fund Insights - REITs QDII funds led the performance with a return of 2.41%, followed by equity funds focused on Europe and the US, which returned 1.70% [17][18] - The report notes that alternative asset classes, particularly gold-related QDII funds, have shown significant year-to-date growth of 25.91% despite a recent decline of 1.39% [17][18] - Representative QDII funds such as Morgan China Biopharmaceutical A and GF CSI Hong Kong Innovative Medicine ETF reported returns of 4.72% and 4.56%, respectively, during the period [19]